KACI MONHART: Open Payments
NPI 1053033290 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,934 in 28 payments from 7 companies in 2025. Trend: 2023 $115 · 2024 $1,112 · 2025 $1,934
Honoraria: $1,080Food & beverage: $844Speaker / faculty: $10
| Company | Payments | Amount |
|---|---|---|
| MDD US Operations, LLC | 19 | $1,453 |
| Boston Scientific Corporation | 1 | $136 |
| Neurocrine BioSciences, Inc. | 1 | $129 |
| Cala Health, Inc. | 1 | $90 |
| ABBVIE INC. | 3 | $54 |
| ACADIA Pharmaceuticals Inc | 2 | $48 |
| Xeris Pharmaceuticals, Inc. | 1 | $25 |
Products named: Gocovri, General - DBS, INGREZZA, Cala kIQ, NUPLAZID, VYALEV, KEVEYIS, QULIPTA.
Industry payments across PA — which companies pay providers there.
